Tamarack Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-900,000
Closed -$14M 36
2015
Q1
$14M Sell
900,000
-460,000
-34% -$6.95M 1.85% 20
2014
Q4
$18.7M Buy
1,360,000
+940,000
+224% +$11.5M 2.84% 12
2014
Q3
$4.2M Buy
+420,000
New +$4.29M 0.93% 27
2014
Q1
Sell
-1,240,000
Closed -$11M 25
2013
Q4
$11M Sell
1,240,000
-67,176
-5% -$532K 2.6% 14
2013
Q3
$9.22M Sell
1,307,176
-92,824
-7% -$588K 2.44% 17
2013
Q2
$7.86M Buy
+1,400,000
New +$6.71M 4.4% 10

Other funds holding DXCM

Tamarack Capital Management's DXCM Position: Q2 2015 in Review

Tamarack Capital Management sold out of DexCom (DXCM) in Q2 2015, closing a stake of 900,000 shares — an estimated $14M sold.

Tamarack Capital Management first reported a position in DXCM in Q2 2013 and held it in 6 quarters. The position peaked at $18.7M in Q4 2014. 257 funds tracked by Wall St. Rank hold DXCM as of Q2 2015.

  • Tamarack Capital Management reported no remaining DexCom position as of Q2 2015 after selling out during the quarter.
  • Tamarack Capital Management sold 900,000 DexCom shares in Q2 2015, an estimated $14M.
  • Tamarack Capital Management first reported a position in DexCom in Q2 2013 and held it in 6 quarters.
  • Tamarack Capital Management's DexCom position peaked at $18.7M in Q4 2014.
  • 257 funds tracked by Wall St. Rank held DexCom as of Q2 2015.

Based on Tamarack Capital Management's 13F filing for Q2 2015, filed 11 Aug 2015.